DLX5 Antibody

Code CSB-PA006956GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
DLX5
Alternative Names
DLX5Homeobox protein DLX-5 antibody
Species Reactivity
Human,Mouse,Rat
Immunogen
Human DLX5
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA
Protocols
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. Binds to the homeodomain-response element of the ALPL and SP7 promoter. Binds to the MYC promoter. Requires the 5'-TAATTA-3' consensus sequence for DNA-binding.
Gene References into Functions
  1. Our results in mice suggest that long-range DLX5 enhancer elements located in the human SLC25A13 gene may underlie the sensorineural hearing loss that is sometimes associated with SHFM1. PMID: 29301908
  2. These results indicate activation of DLX5 and RUNX2 via its distal promoter represents a unique feature of GFs, and is important for ECM regulation. Down-regulation of these transcription factors in PAFs could be associated with their property to degrade collagen, which may impact on the process of periodontitis. PMID: 27645561
  3. these findings indicate that, in MSCs, DLX5 is a master regulator of osteogenesis. Furthermore, tanshinone IIA may be valuable for stem cell-based therapies of certain bone diseases. PMID: 28949384
  4. As a result of disturbed imprinting, the upregulated DLX5 affects trophoblast proliferation in preeclampsia. PMID: 28904069
  5. These data indicate that certain missense mutations diminish the ability of the Dlx5 homeodomain to recognize and bind target DNAs, and they likely destabilize the formation of functional complexes. PMID: 26829219
  6. In cells grown on titanium support, DLX5 and RUNX1 were respectively upregulated (+3.12-fold) and downregulated (-2.14-fold) PMID: 25025858
  7. Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I. PMID: 25332435
  8. Heterozygous DLX5 nonsense mutation c.G115T(p.E39X) associated with isolated split-hand/foot malformation with reduced penetrance and variable expressivity in two unrelated Polish families. PMID: 25196357
  9. A novel heterozygous mutation in exon 3 of DLX5 found in the family members with SHFM1 phenotype. PMID: 24496061
  10. Genome sequencing of the deletion breakpoints showed that the DLX5 and DLX6 genes are disomic but the putative DYNC1I1 exon 15 and 17 enhancers are deleted. PMID: 24459211
  11. The duplicated region harbors only DLX5 and DLX6, which are known for their role in SHFM1. PMID: 23169702
  12. The strongest evidence for altered methylation patterns in shiftworkers was observed for DLX5 gene. PMID: 23193016
  13. Cyclic tensile stress may induce differentiation of periodontal ligament stem cells towards mineralized tissue cells by promoting Dlx5 mRNA expression and decreasing Msx2 expression. PMID: 22332551
  14. Two patients that have in common a p63-Dlx5/Dlx6 pathway dysregulation. PMID: 22342398
  15. the first intragenic DLX5 mutation in split hand and foot malformation is found; a potential dual role for DLX5 in limb development is suggested PMID: 22121204
  16. DLX5 is significantly increased in heart tissue from calcific aortic valve patients compared to controls. PMID: 21205918
  17. MDA-MB-231 breast neoplasms did not express DLX5 but the resulting bone/lung metastases did. PMID: 21108812
  18. Data suggest that DLX5 plays a significant role in the pathogenesis of some ovarian cancers by enhancing IRS-2-AKT signaling. PMID: 21045156
  19. p63 binds to an enhancer element in the SHFM1 locus and this element controls expression of DLX6 and DLX5 which are important for limb development. PMID: 20808887
  20. Results describe the expression of DLX5 and DLX6 in autistic spectrum disorder patients in an attempt to identify potential abnormality of expression. PMID: 19195802
  21. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. PMID: 11959851
  22. DLX5 was confirmed to be imprinted in normal human lymphoblasts and brain tissues by a polymorphic analysis PMID: 12782124
  23. DLX5 is a target for MeCP2, linking genomic imprinting and Rett syndrome [review] PMID: 15954098
  24. In dental follicle cells, gene expression of runx2, DLX-5, and MSX-2 was unaffected during osteogenic differentiation in vitro. PMID: 16467978
  25. high expression of mutated MECP2 in TRD mutation showed bialleic expression of DLX5 suggesting loss of imprinting PMID: 17363207
  26. DLX5 and DLX6 are not imprinted in humans and are not likely to be direct targets of MeCP2 modulation. PMID: 17701895
  27. Dlx5 can act as an oncogene by cooperating with Akt2 to promote lymphomagenesis PMID: 18316591
  28. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients. PMID: 18413826
  29. The MYC promoter is specifically activated by overexpression of DLX5. PMID: 19497851
  30. Dlxin-1 binds Dlx5 and several additional homeodomain proteins and may regulate the function of Dlx family members in bone formation PMID: 11084035

Show More

Hide All

Involvement in disease
Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive (SHFM1D)
Subcellular Location
Nucleus.
Protein Families
Distal-less homeobox family
Database Links

HGNC: 2918

OMIM: 220600

KEGG: hsa:1749

STRING: 9606.ENSP00000222598

UniGene: Hs.99348

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*